An analysis of the T-cells in the tumor nodules showed a significant increase in CD8+ cells in the tumors from cDCV-treated mice compared to tumors from control mice (Figure 5A), while anti-CTLA-4 treatment alone had no effect on CD8+ cell infiltration in the tumor. The gene discussed is CD8A; the disease is neoplasm.